Showing results (11-20 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|March 11, 2011
Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines surveyDouglas J Opel, Rita Mangione-Smith, James A Taylor, et al.Human Vaccines|March 11, 2011
Private-sector vaccine purchase costs and insurer payments: a disincentive for using combination vaccines?Sarah J Clark, Anne E Cowan, Gary L FreedHuman Vaccines|May 7, 2011
Epidemiological changes after PCV7 implementation in Italy: perspective for new vaccinesFilippo Ansaldi, Daniela de Florentis, Paola Canepa, et al.Human Vaccines|May 10, 2011
Inverse correlation between varicella severity and level of anti-Varicella Zoster Virus maternal antibodies in infants below one year of ageDidier Pinquier, Aurélie Lécuyer, Corinne Levy, et al.Human Vaccines|March 23, 2011
Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinationsAngelika Banzhoff, Sabine Haertel, Michaela PrausHuman Vaccines|March 23, 2011
Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinicReshma Singh, Anu WallechaHuman Vaccines|March 29, 2011
Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of ageVincent Gajdos, Benoit Soubeyrand, Emmanuel Vidor, et al.Human Vaccines|March 29, 2011
Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)Penelope H Dennehy, Timo Vesikari, David O Matson, et al.Human Vaccines|March 2, 2011
Safety of plant-made pharmaceuticals: product development and regulatory considerations based on case studies of two autologous human cancer vaccinesDaniel TuséPageof 64